Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,272 public trials 686 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors

NCT02045602

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Hospital Vall d'Hebron Barcelona, Spain
  • Institut Català d'Oncologia L'Hospitalet de Llobregat, Spain
  • Centro Integral Oncológico Clara Campal Madrid, Spain
  • Hospital Universitario Ramón y Cajal Madrid, Spain
View Trial Details
Completed

Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer

NCT01896856

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • VU Medisch Centrum Amsterdam, Netherlands
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers

NCT02919696

Conditions
Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China
View Trial Details

Related conditions